Open AccessThe safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo
Author(s) -
Kremer Joel M.,
Bloom Bradley J.,
Breedveld Ferdinand C.,
Coombs John H.,
Fletcher Mark P.,
Gruben David,
Krishnaswami Sriram,
BurgosVargas Rubén,
Wilkinson Bethanie,
Zerbini Cristiano A. F.,
Zwillich Samuel H.
Publication year - 2012
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/art.34506
Subject(s) - rheumatism , medicine , rheumatoid arthritis , placebo , arthritis , gastroenterology , surgery , pathology , alternative medicine